Deep Dive: Deep Dive Into Pafolacianine

Phillip S. Low, PhD, discusses the recent approval of pafolacianine for patients with lung cancer. Low, the pioneer behind this imaging agent talked about how this can be of great importance for patients in this population. Additionally, he reviewed how doctors can begin to implement this into practice to best help find and detect cancerous lesions.